On July 15, 2025, CapsoVision, Inc. entered into a $4.1 million agreement with Canon Inc. for developing image sensor samples to enhance future capsule endoscopes. Additionally, they reported on July 16, 2025, a net gain of approximately $600,000 from the exercise of underwriters' overallotment option for 129,978 shares.